These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 3578343

  • 21. Phenelzine-induced myocardial injury: a case report.
    Ngo AS, Ho RY, Olson KR.
    J Med Toxicol; 2010 Dec; 6(4):431-4. PubMed ID: 20652662
    [Abstract] [Full Text] [Related]

  • 22. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA.
    Ned Tijdschr Geneeskd; 2003 Oct 04; 147(40):1940-3. PubMed ID: 14574774
    [Abstract] [Full Text] [Related]

  • 23. [Hypertension en orthostatic hypotension during use of monoamine oxidase (MAO) inhibitors].
    Zandee WT, Alsma J, Birkenhäger TK, den Meiracker AHV, van Hoek M, Versmissen J.
    Tijdschr Psychiatr; 2017 Oct 04; 59(6):366-371. PubMed ID: 28613369
    [Abstract] [Full Text] [Related]

  • 24. Acute hypertensive crisis and severe headache after concurrent use of armodafinil and tranylcypromine: Case report and review of the literature.
    Kinslow CJ, Shapiro SD, Grunebaum MF, Miller EC.
    J Neurol Sci; 2018 Oct 15; 393():1-3. PubMed ID: 30077942
    [Abstract] [Full Text] [Related]

  • 25. Do antihypertensives make tranylcypromine safer? Three case reports.
    Taylor BP, Quitkin FM, McGrath PJ, Stewart JW.
    J Clin Psychiatry; 2005 May 15; 66(5):657-8. PubMed ID: 15889959
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Selective inhibitors of monoamine oxidase type B and the "cheese effect".
    Finberg JP, Gillman K.
    Int Rev Neurobiol; 2011 May 15; 100():169-90. PubMed ID: 21971008
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Withdrawal and discontinuation phenomena associated with tranylcypromine: a systematic review.
    Gahr M, Schönfeldt-Lecuona C, Kölle MA, Freudenmann RW.
    Pharmacopsychiatry; 2013 Jun 15; 46(4):123-9. PubMed ID: 23359339
    [Abstract] [Full Text] [Related]

  • 35. The monoamine oxidase inhibitor-tyramine interaction.
    Brown C, Taniguchi G, Yip K.
    J Clin Pharmacol; 1989 Jun 15; 29(6):529-32. PubMed ID: 2666453
    [Abstract] [Full Text] [Related]

  • 36. HYPERTENSIVE CRISIS DUE TO MONOAMINE-OXIDASE INHIBITORS.
    BLACKWELL B.
    Lancet; 1963 Oct 26; 2(7313):849-50. PubMed ID: 14056007
    [No Abstract] [Full Text] [Related]

  • 37. Will amitriptyline prevent the "cheese" reaction of monoamine-oxidase inhibitors?
    Pare CM, Kline N, Hallstrom C, Cooper TB.
    Lancet; 1982 Jul 24; 2(8291):183-6. PubMed ID: 6123888
    [Abstract] [Full Text] [Related]

  • 38. [Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases].
    Oostervink F, Bouvy PF, Touw DJ.
    Ned Tijdschr Geneeskd; 2003 Oct 04; 147(40):1937-40. PubMed ID: 14574773
    [Abstract] [Full Text] [Related]

  • 39. Tyramine studies and the safety of MAOI drugs.
    Simpson GM, White K.
    J Clin Psychiatry; 1984 Jul 04; 45(7 Pt 2):59-61. PubMed ID: 6735997
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.